Participant Selection: The study recruited 469 participants from primary care settings (GP surgeries) who had been taking antidepressants for at least six weeks and still met the criteria for clinical depression (BDI score ).
Intervention Protocol: The experimental group received 12 to 18 sessions of individual CBT, each lasting approximately 50-60 minutes. These sessions were delivered by trained therapists and focused on standard CBT techniques like behavioral activation and cognitive restructuring.
Measurement Tool: The primary outcome measure was the Beck Depression Inventory (BDI). This is a 21-item self-report scale that assesses the severity of depressive symptoms. A 'response' to treatment was defined as a 50% or greater reduction in the BDI score from the baseline.
| Feature | Usual Care (Control) | CBT + Usual Care (Experimental) |
|---|---|---|
| Primary Treatment | Continued antidepressant medication | Continued medication + 12-18 CBT sessions |
| Mechanism | Biological/Neurochemical focus | Biological + Cognitive/Behavioral focus |
| Success Rate | Approximately 22% showed response | Approximately 46% showed response |
| Long-term Goal | Symptom management via chemistry | Skill acquisition and cognitive change |
Response vs. Remission: It is critical to distinguish between a 'response' (significant improvement, e.g., 50% reduction in symptoms) and 'remission' (complete absence of symptoms). The Wiles study primarily focused on the response rate as the indicator of effectiveness.
Primary Care vs. Secondary Care: Unlike many studies conducted in specialized psychiatric hospitals, this study focused on primary care (GPs), making the findings more applicable to the general population seeking help for depression.
Identify the Sample: Always remember that the participants were 'treatment-resistant.' This is a specific subgroup. If an exam question asks about depression in general, specify that Wiles' findings are particularly strong for those who didn't find relief through medication alone.
Quantify the Success: Memorize the '46% vs 22%' statistic. Being able to cite that the CBT group was roughly twice as likely to show a significant clinical response is a high-yield point for evaluation sections.
Methodological Strengths: When evaluating the study, highlight the use of a Randomized Controlled Trial (RCT) and the large sample size (). These factors increase the internal validity and the power of the statistical findings.
Check for Attrition: In longitudinal studies, always check if participants dropped out. Wiles had a relatively low attrition rate, which strengthens the reliability of the 12-month follow-up data.
The 'Cure' Misconception: Students often assume CBT 'cured' the depression. In reality, the study showed significant improvement and reduction in symptoms, but many patients still experienced some level of depressive symptoms.
Medication Replacement: A common error is stating that CBT replaced the medication. The study specifically tested CBT as an adjunct (addition) to medication. The control group did not stop their medication; they simply didn't receive the therapy.
Generalizability: While the sample was large, it was limited to the UK. One should be cautious when applying these specific percentage outcomes to different cultural or healthcare contexts without further evidence.
